MINUTES OF THE DESERT SHIELD MEDICAL ISSUES WORKING GROUP

File: 970101_sep96_decls22_0002.txt
Page: 0002
Total Pages: 3

Subject: MINUTES OF THE DESERT SHIELD MEDICAL ISSUES WORKING GROUP       

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003205

Folder Title: MINUTES OF THE DESERT SHIELD MEDICAL ISSUES WORKING GROUP                                       

Document Number:          1

Folder Seq  #:         38








             SUBJECT: Minutes of the operation Desert Shield Medical Issues
             Working Group


             predeployment (2 doses) and be given to recruits. For the
             present, we should rely on ISG in Saudi Arabia as long as it is
             available. COL Bancroft will check on price/availability of the
             Hepatitis A vaccine and report at the next meeting.

                 d. Centoxin. COL Bancroft stated that there are presently
             80 doses at the MEDSOM for all services. He supported the
             tri-service recommendation to use Centoxin for prophylaxis to
             all wounded personnel with abdominal, chest, burn, and head
             trauma. He stated that it would supplement and not replace any
             other treatment. USAMRDC is negotiating for an additional 600
             doses.

                 e. Establishment of a "Manhattan Project" was discussed to
             evaluate vaccines in Saudi Arabia was discussed. Committee
             'members felt that the timing for trials in theater was not right
             at present. There is too much else going on right now. If
             Operation Desert Shield becomes a prolonged operation, then
             trials may be possible.

                 f. The committee also discussed the tri-service conmittee's
             recommendations to create a tri-service research task force and
             to provide appropriate funding to accomplish the mission.

             3. Recommendations:

                 a. Research availability, shelf life, etp. on the oral
             cholera vaccine and present to BG Slanck and TSG.
                 b. Pursue Typhoid TY21a vaccine for its long term viability
             but do not pursue for use in Operation Desert Shield.
                 c. Research availability and cost of Hepatitis A vaccine.
             Continue to rely on ISG in Saudi Arabia. When available and
             efficacy demonstrated, use Hepatitis A for prodeployment (2
   doses) and for recruits.

                 d. Use centoxin for prophylaxis as recommended by
             tri-service committee.

                 e. Refer recommendations of the tri-service committee
             concerning establishment of a "Manhattan Project", creation of a
             tri-service research task force, and funding for the mission to
             the Joint Technology Coordinating Group.


                                              2

Document 3 f:/Week-36/BX003205/MINUTES OF THE DESERT SHIELD MEDICAL ISSUES WORKING GROUP/minutes of the desert shield medical issues work:12249609312523
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003205
Unit = OTSG
Parent Organization = HSC
Folder Title = MINUTES OF THE DESERT SHIELD MEDICAL ISSUES WORKING GROUP
Folder Seq # = 38
Subject = MINUTES OF THE DESERT SHIELD MEDICAL ISSUES WORK
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 24-DEC-1996